Study of Royal Jelly effect on serum levels of IL-4, TNF- α, TGF-B, and IFN-γ in multiple sclerosis patients in comparison with Omega-3; A double-blind, randomized, clinical trial.

Key Points

• This research aims to investigate the effects of royal jelly and omega-3 on cytokine levels in multiple sclerosis patients.
• Conducted as a double-blind, randomized clinical trial
• Compared serum levels of IL-4, TNF-α, TGF-β, and IFN-γ
• Included multiple sclerosis patients as the target population
• Indications that both royal jelly and omega-3 may positively influence cytokine levels in MS patients
• No specific quantitative data provided in the abstract